Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Frontiers in Digital Health|July 16, 2026
From voice biomarkers to telemedicine screening: developing and evaluating a voice-based AI model for laryngeal lesion detection using the Bridge2AI-Voice datasetPhillip D Jenkins, Steven Bedrick, Lisa Karstens, et al.
European Biophysics Journal : EBJ|March 5, 2011
Water flux through human aquaporin 1: inhibition by intracellular furosemide and maximal response with high osmotic gradientsMarcelo Ozu, Ricardo A Dorr, M Teresa Politi, et al.
British Journal of Clinical Pharmacology|April 24, 1999
The pharmacokinetics and safety profile of oral ganciclovir in combination with trimethoprim in HIV- and CMV-seropositive patientsD Jung, M H AbdelHameed, J Hunter, et al.
The American Journal of Managed Care|January 18, 2007
Productivity enhancement for primary care providers using multicondition care managementDavid A Dorr, Adam Wilcox, K John McConnell, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Towards augmenting structured EHR data: a comparison of manual chart review and patient self-reportNicole G Weiskopf, Aaron M Cohen, Joely Hannan, et al.
Health Services Research|September 22, 2005
Impact of generalist care managers on patients with diabetesDavid A Dorr, Adam Wilcox, Steven M Donnelly, et al.
Paediatric Drugs|April 20, 2001
Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in childrenC Oo, J Barrett, G Hill, et al.
Journal of the American Board of Family Medicine : JABFM|July 18, 2020
The Ability of Practices to Report Clinical Quality Measures: More Evidence of the Size Paradox?Michael L Parchman, Melissa L Anderson, Robert B Penfold, et al.
Journal of the American Medical Informatics Association : JAMIA|February 8, 2023
Healthcare utilization is a collider: an introduction to collider bias in EHR data reuseNicole G Weiskopf, David A Dorr, Christie Jackson, et al.
Journal of Clinical Pharmacology|August 10, 2000
The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteersJ W Massarella, G Z He, A Dorr, et al.
Pageof 19